rheumatoid arthritis

Oct 29, 2021

Zeus Scientific Acquires Rights to Synthetic Peptides From Sheba Medical Center

Mar 29, 2021

Exagen, Emory University to Study of Long-Term Effects of COVID-19 on Autoimmune Disease

Mar 24, 2021

Scipher Medicine Raises $82M in Series C Financing

Jan 5, 2021

Myriad Genetics to Sell Vectra DA Business, Reorganize International Presence

Sep 17, 2020

Scipher Medicine Taps Ambry Genetics to Scale Up TNF Inhibitor Response Test

Aug 5, 2020

Scipher Medicine to Launch PrismRA Anti-TNF Response Predictor Following Positive Data Publication

Jun 9, 2020

Judge Allows Whistleblower Suit Against Myriad Genetics to Proceed

May 11, 2020

Exagen Q1 Revenues Grow 3 Percent

Apr 25, 2020

Genalyte Acquires BaseHealth

Apr 17, 2020

Svar Life Science, Nimble Therapeutics Form Diagnostics Alliance

Mar 9, 2020

Theradiag Kits for Biotherapy Monitoring Get CE Marks

Feb 19, 2020

Scipher Medicine Raises Series B Financing Total to $25M

Dec 19, 2019

Scipher Medicine Closes Series B Funding Round

Dec 5, 2019

Immunovia's RA, Lung Cancer Tests Progress Through Partnerships with LUMC, Pharma
Premium

Dec 3, 2019

Myriad Hopes Guideline Inclusion, Additional Risk Data Will Drive Uptake of Vectra Test
Premium

Nov 25, 2019

After IPO, Exagen Seeks to Make Further Strides in Autoimmune Diagnostics
Premium

May 29, 2019

FDA Clears Inova Diagnostics Rheumatoid Arthritis Assays

Feb 14, 2019

Increased Monitoring of Biologics Could Boost Demand for T-mAb Testing
Premium

Jan 30, 2019

New Assay Sheds Light on New Strategies for Arthritis Drug

Jan 11, 2019

Vectra DA Rheumatoid Arthritis Dx Studies Detail New Test Model, Clinical Utility Data
Premium